vs
Altimmune, Inc.（ALT）与VTEX（VTEX）财务数据对比。点击上方公司名可切换其他公司
VTEX的季度营收约是Altimmune, Inc.的1.6倍（$42.3K vs $26.0K）
Altimmune是一家处于临床阶段的生物制药企业，专注于研发免疫疗法、疫苗及肽类疗法，管线覆盖传染病预防、肝脏疾病与代谢类疾病治疗领域，主要面向全球生物制药与医疗保健市场，推进候选药物的临床试验及后续商业化工作。
VTEX是全球领先的云原生数字商务平台提供商，为客户提供电商搭建、订单管理、线上线下零售场景打通等全渠道解决方案，主要服务零售、快消、制造等领域的中大型企业，在拉美、北美及欧洲市场拥有成熟布局。
ALT vs VTEX — 直观对比
营收规模更大
VTEX
是对方的1.6倍
$26.0K
损益表 — Q4 FY2025 vs Q3 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $26.0K | $42.3K |
| 净利润 | — | $-7.9K |
| 毛利率 | — | 65.5% |
| 营业利润率 | — | — |
| 净利率 | — | -18.7% |
| 营收同比 | 420.0% | — |
| 净利润同比 | -18.0% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALTVTEX
| Q4 25 | $26.0K | — | ||
| Q3 25 | $5.0K | — | ||
| Q2 25 | $5.0K | — | ||
| Q1 25 | $5.0K | — | ||
| Q4 24 | $5.0K | — | ||
| Q3 24 | $5.0K | $42.3K | ||
| Q2 24 | $5.0K | — | ||
| Q1 24 | $5.0K | — |
净利润ALTVTEX
| Q4 25 | — | — | ||
| Q3 25 | $-19.0M | — | ||
| Q2 25 | $-22.1M | — | ||
| Q1 25 | $-19.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-22.8M | $-7.9K | ||
| Q2 24 | $-24.6M | — | ||
| Q1 24 | $-24.4M | — |
毛利率ALTVTEX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 65.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ALTVTEX
| Q4 25 | — | — | ||
| Q3 25 | -417180.0% | — | ||
| Q2 25 | -458440.0% | — | ||
| Q1 25 | -436300.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -495340.0% | — | ||
| Q2 24 | -534900.0% | — | ||
| Q1 24 | -535880.0% | — |
净利率ALTVTEX
| Q4 25 | — | — | ||
| Q3 25 | -380280.0% | — | ||
| Q2 25 | -442920.0% | — | ||
| Q1 25 | -391500.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -456900.0% | -18.7% | ||
| Q2 24 | -492800.0% | — | ||
| Q1 24 | -487880.0% | — |
每股收益（稀释后）ALTVTEX
| Q4 25 | — | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | $-0.27 | — | ||
| Q1 25 | $-0.26 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.32 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q1 24 | $-0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $273.5M | $28.0M |
| 总债务越低越好 | $34.3M | — |
| 股东权益账面价值 | $224.9M | $240.3M |
| 总资产 | $279.9M | $341.1M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资ALTVTEX
| Q4 25 | $273.5M | — | ||
| Q3 25 | $210.8M | — | ||
| Q2 25 | $183.1M | — | ||
| Q1 25 | $149.8M | — | ||
| Q4 24 | $131.9M | — | ||
| Q3 24 | $139.4M | $28.0M | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $182.0M | — |
总债务ALTVTEX
| Q4 25 | $34.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALTVTEX
| Q4 25 | $224.9M | — | ||
| Q3 25 | $185.6M | — | ||
| Q2 25 | $161.4M | — | ||
| Q1 25 | $142.2M | — | ||
| Q4 24 | $123.5M | — | ||
| Q3 24 | $133.4M | $240.3M | ||
| Q2 24 | $152.5M | — | ||
| Q1 24 | $172.9M | — |
总资产ALTVTEX
| Q4 25 | $279.9M | — | ||
| Q3 25 | $218.4M | — | ||
| Q2 25 | $190.3M | — | ||
| Q1 25 | $157.3M | — | ||
| Q4 24 | $139.3M | — | ||
| Q3 24 | $147.9M | $341.1M | ||
| Q2 24 | $173.3M | — | ||
| Q1 24 | $188.4M | — |
负债/权益比ALTVTEX
| Q4 25 | 0.15× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-67.5M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | $-67.5M | — |
| 自由现金流率自由现金流/营收 | -259792.3% | — |
| 资本支出强度资本支出/营收 | 42.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ALTVTEX
| Q4 25 | $-67.5M | — | ||
| Q3 25 | $-11.9M | — | ||
| Q2 25 | $-19.4M | — | ||
| Q1 25 | $-16.8M | — | ||
| Q4 24 | $-79.8M | — | ||
| Q3 24 | $-27.1M | $27.3M | ||
| Q2 24 | $-18.1M | — | ||
| Q1 24 | $-16.4M | — |
自由现金流ALTVTEX
| Q4 25 | $-67.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ALTVTEX
| Q4 25 | -259792.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ALTVTEX
| Q4 25 | 42.3% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
